ImageneBio, Inc. (IMA) — Financial Flexibility Index
ImageneBio, Inc. (IMA) has a Financial Flexibility Index of -1.11x as of March 2026. Free cash flow of $-14.80 Million (operating CF $-14.80 Million minus capex $0.00) represents -1% of total liabilities ($13.36 Million). Check ImageneBio, Inc. PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ImageneBio, Inc. Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for ImageneBio, Inc. across 8 annual periods. See ImageneBio, Inc. (IMA) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for ImageneBio, Inc. (2018–2025)
Year-by-year free cash flow to debt coverage for ImageneBio, Inc.. For the full company profile including market capitalisation, see ImageneBio, Inc. stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.41x | $-47.84 Million | $-47.84 Million | $19.84 Million | ▲ +18.3% |
| 2024 | -2.95x | $-46.00 Million | $-46.00 Million | $15.58 Million | ▲ +16.8% |
| 2023 | -3.55x | $-79.33 Million | $-79.74 Million | $22.34 Million | ▼ -23.6% |
| 2022 | -2.87x | $-72.68 Million | $-74.11 Million | $25.29 Million | ▼ -96.5% |
| 2021 | -1.46x | $-58.49 Million | $-60.25 Million | $40.00 Million | ▼ -963.1% |
| 2020 | -0.14x | $-37.06 Million | $-37.83 Million | $269.45 Million | ▼ -142.0% |
| 2019 | 0.33x | $48.24 Million | $47.93 Million | $147.44 Million | ▲ +292.6% |
| 2018 | -0.17x | $-11.30 Million | $-11.61 Million | $66.52 Million | — |